We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Cmc2.5
Camu Camu Research
Mostly mechanism / observational
8 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Camu Camu studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2000–2025 with a typical study size of 30 participants.
Based on 8 studies · 2 RCTs · 30 total participants
Confidence
Low confidence
Active research area
5 studies in the last 5 years
200020122025
1Review2025
In plain English: This review brings to the forefront the importance of Myrciaria dubia as a tool for addressing modern health challenges while supporting biodiversity conservation.
Maqsood S, Arshad MT, Ikram A, Gnedeka KT. · Food science & nutrition (2025)
The bioactive profile of Myrciaria dubia comprises vitamin C, polyphenols, flavonoids, anthocyanins, and ellagic acid, contributing to its metabolic, anti-inflammatory, antioxidant, and antibacterial actions.
Comparative analyses suggest its bioavailability and beneficial activity surpass those of other fruits, making it a strong candidate for functional foods, beverages, cosmetics, and pharmaceuticals.
Given its promising attributes, further investigation and biotechnological advancements are necessary to enhance its bioactive content and ensure its sustainable integration into global markets.
In plain English: The manuscript concludes that, although preclinical studies suggest potential benefits of these plants in the context of cardiodiabesity, more well-designed clinical studies are needed to validate their efficacy and safety, establish appropriate dosages, and better understand the molecular mechanisms involved in their therapeutic effects.
Dias BP, Dantas HVP, de Barros Neto J, Teixeira TACC, da Silva HR, Aytar EC, Carvalho JCT. · Inflammopharmacology (2025)
Effective management of this syndrome requires a holistic approach, including lifestyle modifications, pharmacological interventions, and complementary therapies.
Despite the promising potential of these medicinal plants, the study identifies significant gaps in current knowledge, primarily due to the scarcity of clinical trials in humans, variability in plant chemical composition, and a lack of standardized extracts.
In plain English: All things considered, the focus of this research was to highlight the bioactive potential and health impact of native fruits from the Amazon and Atlantic Forest biomes.
More recently, these fruits have also been exposed as interesting sources of minor bioactive compounds, such as carotenoids, terpenes, and/or polyphenols, the latter which include anthocyanins, phenolic acids, and tannins.
Although they are still underexplored, several in vitro and in vivo studies with different parts of the fruits, including the peel, seed, and pulp, indicate their health potential through anti-oxidative, anti-obesity, antihyperglycemic, antidyslipidemic, antimicrobial, and/or anticancer effects.
All things considered, the focus of this research was to highlight the bioactive potential and health impact of native fruits from the Amazon and Atlantic Forest biomes.
In plain English: These findings support that polyphenol-rich prebiotic may reduce liver fat in adults with overweight, reducing the risk of developing NAFLD.
Agrinier AL, Morissette A, Daoust L, Gignac T, Marois J, Varin TV, Pilon G, Larose É, Gagnon C, Desjardins Y, Anhê FF, Carreau AM, Vohl MC, Marette A. · Cell reports. Medicine (2024)
Non-alcoholic fatty liver disease (NAFLD) affects 25% of the adult population with no effective drug treatments available.
CC treatment decreases liver fat by 7.43%, while it increases by 8.42% during the placebo intervention, showing a significant difference of 15.85%.
A randomized, double-blind, placebo-controlled crossover trial is conducted on 30 adults with overweight and hypertriglyceridemia, who consume 1.5 g of CC capsules or placebo daily for 12 weeks.
In plain English: Camu-camu fruit extract reduced reactive oxygen species and inflammatory signaling and activated the Nrf2 antioxidant pathway in cultured human keratinocytes.
Do NQ, Zheng S, Park B, Nguyen QTN, Choi BR, Fang M, Kim M, Jeong J, Choi J, Yang SJ, Yi TH · Molecules (2021)
In-vitro study in high-glucose-stressed human keratinocytes (skin cells)
Extract reduced ROS and downregulated NF-κB, AP-1 and NFAT-linked inflammatory mediators